Skip to main content

Table 1 Key characteristics and demographic profile of the patients that received MgSO 4

From: Benefits of using magnesium sulphate (MgSO4) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria

Basic characteristics

Pre-eclampsia patients (n = 49)

Eclampsia patients (n = 996)

Total (n = 1045)

 

N (%)

N (%)

N (%)

Age (years)

   

  15-19

19(38.8)

519(52.1)

538(51.5)

  20-24

19(38.8)

312(31.3)

331(31.7)

  25-48

10(20.4)

148(14.9)

158(15.1)

  Unknown

1(2.0)

17(1.7)

18(1.7)

Parity

   

  0

30(61.2)

601(60.3)

631(60.4)

  1-5

13(26.5)

351(35.2)

364(34.8)

  >5

6(12.2)

33(3.3)

39(3.7)

  Unknown

0

11(1.1)

11(1.1)

Educational status

   

  None

36(73.5)

738(74.1)

774(74.1)

  Nursery

3(6.1)

39(3.9)

42(4.0)

  Primary

4(8.2)

138(13.9)

142(13.6)

  Secondary/Vocational

4(8.2)

59(5.9)

63(6.0)

  Tertiary

1(2.0)

4(0.4)

5(0.5)

  Unknown

1(2.0)

18(1.8)

19(1.8)

Marital status

   

  Married (monogamous)

37(75.5)

705(70.8)

742(71.0)

  Married (polygamous)

12(24.5)

289(29.0)

301(28.8)

  Unknown

0

2(0.2)

2(0.2)

Blood pressure on admission

   

  Normal (SBP ≤ 139/DBP ≤ 89)

0

42 (4.2)

42 (4.2)

  Hypertensive (SBP ≥ 140/DBP ≥ 90)

48 (98.0)

940 (94.4)

988 (94.5)

  Unknown

1 (2.0)

14 (1.4)

15 (1.4)